Acknowledgement
This work was supported by Ministry of Higher Education (MOHE), Malaysia through Fundamental Research Grant Scheme (FRGS/1/2019/SKK08/USM/02/17).
References
- Gottlieb S, Esposito RE. A new role for a yeast transcriptional silencer gene, SIR2, in regulation of recombination in ribosomal DNA. Cell 1989;56:771-776. https://doi.org/10.1016/0092-8674(89)90681-8
- Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000;273:793-798. https://doi.org/10.1006/bbrc.2000.3000
- Tanny JC, Dowd GJ, Huang J, Hilz H, Moazed D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 1999;99:735-745. https://doi.org/10.1016/S0092-8674(00)81671-2
- Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 2010;5:253-295. https://doi.org/10.1146/annurev.pathol.4.110807.092250
- Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999;260:273-279. https://doi.org/10.1006/bbrc.1999.0897
- Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A 2002;99:13653-13658. https://doi.org/10.1073/pnas.222538099
- Beier UH, Wang L, Bhatti TR, Liu Y, Han R, Ge G, et al. Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Mol Cell Biol 2011;31:1022-1029. https://doi.org/10.1128/MCB.01206-10
- Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999;13:2570-2580. https://doi.org/10.1101/gad.13.19.2570
- Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 2004;101:15998-16003. https://doi.org/10.1073/pnas.0404184101
- Herranz D, Munoz-Martin M, Canamero M, Mulero F, Martinez-Pastor B, Fernandez-Capetillo O, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 2010;1:3.
- Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 2013;18:416-430. https://doi.org/10.1016/j.cmet.2013.07.013
- Zhao L, Cao J, Hu K, He X, Yun D, Tong T, et al. Sirtuins and their biological relevance in aging and age-related diseases. Aging Dis 2020;11:927-945. https://doi.org/10.14336/AD.2019.0820
- Lin Z, Fang D. The roles of SIRT1 in cancer. Genes Cancer 2013;4:97-104. https://doi.org/10.1177/1947601912475079
- Chalkiadaki A, Guarente L. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer 2015;15:608-624. https://doi.org/10.1038/nrc3985
- Guarente L. Sirtuins in aging and disease. Cold Spring Harb Symp Quant Biol 2007;72:483-488. https://doi.org/10.1101/sqb.2007.72.024
- Fortuny L, Sebastian C. Sirtuins as metabolic regulators of immune cells phenotype and function. Genes (Basel) 2021;12:1698.
- Carafa V, Rotili D, Forgione M, Cuomo F, Serretiello E, Hailu GS, et al. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics 2016;8:61.
- Dai H, Sinclair DA, Ellis JL, Steegborn C. Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol Ther 2018;188:140-154. https://doi.org/10.1016/j.pharmthera.2018.03.004
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504. https://doi.org/10.1101/gr.1239303
- Kerrien S, Alam-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C, et al. IntAct: open source resource for molecular interaction data. Nucleic Acids Res 2007;35:D561-D565. https://doi.org/10.1093/nar/gkl958
- Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, et al. MINT: the Molecular INTeraction database. Nucleic Acids Res 2007;35:D572-D574. https://doi.org/10.1093/nar/gkl950
- Orchard S, Kerrien S, Abbani S, Aranda B, Bhate J, Bidwell S, et al. Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat Methods 2012;9:345-350. https://doi.org/10.1038/nmeth.1931
- Millan PP. Visualization and analysis of biological networks. Methods Mol Biol 2013;1021:63-88. https://doi.org/10.1007/978-1-62703-450-0_4
- Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res 2019;18:623-632. https://doi.org/10.1021/acs.jproteome.8b00702
- Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, Lo R, et al. InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation. Nucleic Acids Res 2013;41:D1228-D1233. https://doi.org/10.1093/nar/gks1147
- Tacutu R, Thornton D, Johnson E, Budovsky A, Barardo D, Craig T, et al. Human Ageing Genomic Resources: new and updated databases. Nucleic Acids Res 2018;46:D1083-D1090. https://doi.org/10.1093/nar/gkx1042
- Sondka Z, Bamford S, Cole CG, Ward SA, Dunham I, Forbes SA. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat Rev Cancer 2018;18:696-705. https://doi.org/10.1038/s41568-018-0060-1
- Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics 2008;24:282-284. https://doi.org/10.1093/bioinformatics/btm554
- Morris JH, Apeltsin L, Newman AM, Baumbach J, Wittkop T, Su G, et al. clusterMaker: a multi-algorithm clustering plugin for Cytoscape. BMC Bioinformatics 2011;12:436.
- Enright AJ, Van Dongen S, Ouzounis CA. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 2002;30:1575-1584. https://doi.org/10.1093/nar/30.7.1575
- McGuinness D, McGuinness DH, McCaul JA, Shiels PG. Sirtuins, bioageing, and cancer. J Aging Res 2011;2011:235754.
- Carafa V, Nebbioso A, Altucci L. Sirtuins and disease: the road ahead. Front Pharmacol 2012;3:4.
- Costantini S, Sharma A, Raucci R, Costantini M, Autiero I, Colonna G. Genealogy of an ancient protein family: the sirtuins, a family of disordered members. BMC Evol Biol 2013;13:60.
- Vassilopoulos A, Fritz KS, Petersen DR, Gius D. The human sirtuin family: evolutionary divergences and functions. Hum Genomics 2011;5:485-496. https://doi.org/10.1186/1479-7364-5-5-485
- Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol Endocrinol 2007;21:1745-1755. https://doi.org/10.1210/me.2007-0079
- Greiss S, Gartner A. Sirtuin/Sir2 phylogeny, evolutionary considerations and structural conservation. Mol Cells 2009;28:407-415. https://doi.org/10.1007/s10059-009-0169-x
- Pan M, Yuan H, Brent M, Ding EC, Marmorstein R. SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity. J Biol Chem 2012;287:2468-2476. https://doi.org/10.1074/jbc.M111.285031
- North BJ, Verdin E. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. PLoS One 2007;2:e784.
- Yoon H, Shin SH, Shin DH, Chun YS, Park JW. Differential roles of Sirt1 in HIF-1alpha and HIF-2alpha mediated hypoxic responses. Biochem Biophys Res Commun 2014;444:36-43. https://doi.org/10.1016/j.bbrc.2014.01.001
- Donmez G, Outeiro TF. SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med 2013;5:344-352. https://doi.org/10.1002/emmm.201302451
- White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 2014;46:S7-S15. https://doi.org/10.1016/j.amepre.2013.10.029
- Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331. https://doi.org/10.1016/S0092-8674(00)81871-1
- Blagih J, Buck MD, Vousden KH. p53, cancer and the immune response. J Cell Sci 2020;133:jcs237453.
- Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A 2007;104:16633-16638. https://doi.org/10.1073/pnas.0708043104
- Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007;67:3043-3053. https://doi.org/10.1158/0008-5472.CAN-06-4149
- Oskouian B, Saba JD. Cancer treatment strategies targeting sphingolipid metabolism. Adv Exp Med Biol 2010;688:185-205. https://doi.org/10.1007/978-1-4419-6741-1_13
- Zhang Y, Wang X, Yang H, Liu H, Lu Y, Han L, et al. Kinase AKT controls innate immune cell development and function. Immunology 2013;140:143-152. https://doi.org/10.1111/imm.12123
- Canto C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 2009;20:98-105.
- Kosgei VJ, Coelho D, Gueant-Rodriguez RM, Gueant JL. Sirt1-PPARS cross-talk in complex metabolic diseases and inherited disorders of the one carbon metabolism. Cells 2020;9:1882.
- Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol 2015;17:351-359. https://doi.org/10.1038/ncb3124
- Zhang Y, Wang X. Targeting the Wnt/beta-catenin signaling pathway in cancer. J Hematol Oncol 2020;13:165.
- Ruiz de Galarreta M, Bresnahan E, Molina-Sanchez P, Lindblad KE, Maier B, Sia D, et al. Beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discov 2019;9:1124-1141. https://doi.org/10.1158/2159-8290.CD-19-0074
- Jia L, Pina-Crespo J, Li Y. Restoring Wnt/beta-catenin signaling is a promising therapeutic strategy for Alzheimer's disease. Mol Brain 2019;12:104.